Americans are sliding backward in preparing for retirement, with employees reducing their annual contributions to their 401(k) accounts last year, according to new research from payroll firm Dayforce.

Amid Phoenix-Dayforce switch, feds are clawing back hundreds from her paycheques Public Services and Procurement Canada (PSPC) was chosen to test a replacement system for the troubled Phoenix pay ...

NEW ORLEANS, LA—Mavacamten (Camzyos; Bristol Myers Squibb) better reduces left ventricular outflow tract (LVOT) obstruction than placebo among adolescent patients with obstructive hypertrophic ...

(LEX 18) — Sydney McLaughlin-Levrone has won four Olympic gold medals and countless races on the track at the University of Kentucky, but she says she may be saving her best effort for off the track.

HCM, a hereditary condition, is a leading cause of heart-related disability in younger adults. In this progressive heart disease, the heart muscle abnormally thickens and stiffens, blocking blood flow ...

Shortness of breath, especially during activities that increase the heart rate, can be an early indicator of HCM. Chest pain, which often feels like tightness or pressure, may arise during physical ...

Many symptoms of hypertrophic cardiomyopathy (HCM) are mild, particularly in the early stages of the disease, so they may be easy to dismiss. Symptoms such as shortness of breath during exercise, ...

The FDA on Friday approved aficamten (Myqorzo) for symptomatic obstructive hypertrophic cardiomyopathy (HCM), drugmaker Cytokinetics announced. Aficamten is an allosteric and reversible inhibitor of ...

Aficamten offers a new treatment option for symptomatic obstructive hypertrophic cardiomyopathy (oHCM). Clinical trials SEQUOIA-HCM and MAPLE-HCM showed aficamten's efficacy in improving exercise ...

Please provide your email address to receive an email when new articles are posted on . The FDA approved aficamten to improve functional capacity and symptoms in adults with obstructive hypertrophic ...

MINNEAPOLIS (AP) — MINNEAPOLIS (AP) — Dayforce Inc (DAY) on Wednesday reported a loss of $196.8 million in its third quarter. On a per-share basis, the Minneapolis-based company said it had a loss of ...